Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jennifer Paluch"'
Publikováno v:
Research & Politics, Vol 9 (2022)
Mail voting became unusually controversial in the 2020 presidential election. Many observers, including former President Trump, believed that more accessible vote by mail would encourage higher turnout at the expense of Republicans. While the literat
Externí odkaz:
https://doaj.org/article/1d731551dc0d47fda339ac98a636ffa1
Autor:
Chuan Shih, Kathryn White, Jennifer Paluch, Lisa Polin, Thomas H. Corbett, Juiwanna Kushner, Cora Sue Grossman
Publikováno v:
Investigational New Drugs. 21:33-45
The discoveries of a new antitumor agent (LY32262) (N-[2,4-dichlorobenzoyl]phenylsulfonamide) and a close analog (LY33169) are described. For this discovery, a disk-diffusion-soft-agar-colony-formation-assay was used to screen a portion of the Eli Li
Autor:
Juiwanna Kushner, Chiab Simpson, Matthew Edelstein, Thomas H. Corbett, Susan Pugh, Jennifer Paluch, Jerome P. Horwitz, Lisa Polin, Kathryn White, Stuart T. Hazeldine, Joseph A. Fontana, Patricia LoRusso
Publikováno v:
Investigational New Drugs. 20:13-22
XK-469 is advancing to Phase I clinical trials. Preclinical studies were carried out to assist in clinical applications. DOSE-SCHEDULE ROUTE TESTING: Single dose i.v. treatment with XK-469 produced lethality (LD20 to LD100) above 142 mg/kg. Optimum t
Autor:
Thomas H Corbett, Lisa Polin, Bill J Roberts, Alfred J Lawson, Wilbur R Leopold, Kathryn White, Juiwanna Kushner, Jennifer Paluch, Stuart Hazeldine, Richard Moore, James Rake, Jerome P Horwitz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2876c5df954d9b5def332ba4584f5586
https://doi.org/10.1385/1-59259-100-0:041
https://doi.org/10.1385/1-59259-100-0:041
Autor:
Stuart T. Hazeldine, Juiwanna Kushner, Jerome P. Horwitz, Kathryn White, Eduardo Palomino, Lisa Polin, Jennifer Paluch, Matthew Edelstein, Thomas H. Corbett
Publikováno v:
Journal of medicinal chemistry. 44(11)
2-(4-[(7-Chloro-2-quinoxalinyl)oxy]phenoxy)propionic acid (XK469) is among the most highly and broadly active antitumor agents to have been evaluated in our laboratories and is currently scheduled to enter clinical trials in 2001. The mechanism or me